Literature DB >> 185517

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.

Z Fuks, S Strober, H S Kaplan.   

Abstract

We studied the mechanism of defective binding of sheep erythrocytes to the surface of peripheral blood T lymphocytes (E-rosette-formation) in Hodgkin's disease. The decreased percentage of E-rosette-forming cells (range, 21 to 77 per cent) in 25 patients with Hodgkin's disease was reversed and returned to normal range (52 to 78 per cent) by prior incubation of the T lymphocytes in tissue-culture medium with 20 per cent fetal-calf serum for 18 to 24 hours. The percentage of E-rosette-forming cells was suppressed by additional incubation with serum from patients with Hodgkin's disease (range, 20 to 61 per cent) but not with serum from patients with other neoplasms or from normal subjects (range, 52 to 74 per cent). Only target T lymphocytes from patients with Hodgkin's disease were suppressed by Hodgkin-disease serum. The findings suggest that there is a specific interaction between serum factors and the surface of peripheral blood T lymphocytes in Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185517     DOI: 10.1056/NEJM197612022952301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

Review 2.  Adoptive immunotherapy for Hodgkin's lymphoma.

Authors:  Alana A Kennedy-Nasser; Catherine M Bollard; Cliona M Rooney
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

3.  Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors:  C Moroz; N Lahat; M Biniaminov; B Ramot
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

Review 4.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

5.  Pathophysiological aspects of Hodgkin's disease.

Authors:  D Huhn
Journal:  Klin Wochenschr       Date:  1979-05-16

6.  Effect of sera from patients with Hodgkin's disease on normal donor lymphocytes containing parallel tubular structures.

Authors:  J W Smit; N R Blom; M J van Luyn; G W van Imhoff; M R Halie
Journal:  Blut       Date:  1984-02

7.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

8.  Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Authors:  S Gupta; G Fernandes
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

9.  Monocyte function in Hodgkin's disease.

Authors:  G Holm; M Björkholm; B Johansson; H Mellstedt; C Lindemalm
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].

Authors:  H W Pees; G Girmann; J Schwamborn
Journal:  Blut       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.